Krishnan, K <br/><br/>
Prostaglandin inhibitors and the chemoprevention of noncolonic malignancy.  [electronic resource] 

 -  Gastroenterology clinics of North America  Dec 2001 
 - 981-1000 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0889-8553 
<br/><br/><label>Standard No.: </label>10.1016/s0889-8553(05)70224-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--physiopathology<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Barrett Esophagus--physiopathology<br/>Carcinoma, Squamous Cell--physiopathology<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--therapeutic use<br/>Disease Progression<br/>Esophageal Neoplasms--physiopathology<br/>Humans<br/>Isoenzymes--antagonists & inhibitors<br/>Membrane Proteins<br/>Prostaglandin Antagonists--therapeutic use<br/>Prostaglandin-Endoperoxide Synthases<br/>Stomach Neoplasms--physiopathology